Accessibility Menu
Merck KGaA logo

Merck KGaA

(OTC) MKKGY

Current Price$33.75
Market Cap$21.81B
Since IPO (2007)+246%
5 Year-6%
1 Year+30%
1 Month+11%

Merck KGaA Financials at a Glance

Market Cap

$21.81B

Revenue (TTM)

€20.91B

Net Income (TTM)

€2.53B

EPS (TTM)

$1.35

P/E Ratio

24.99

Dividend

$0.51

Beta (Volatility)

0.73 (Low)

Price

$33.75

Volume

79,617

Open

$33.73

Previous Close

$33.75

Daily Range

$33.46 - $34.19

52-Week Range

$23.73 - $34.19

Estimated Earnings Date

Aug 6, 2026

MKKGY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Merck KGaA

Industry

Pharmaceuticals

Employees

62,477

CEO

Belén Garijo López, MD

Headquarters

Darmstadt, 64293, DE

MKKGY Financials

Key Financial Metrics (TTM)

Gross Margin

58.53%

Operating Margin

19.41%

Net Income Margin

12.09%

Return on Equity

8.77%

Return on Capital

9.63%

Return on Assets

4.77%

Earnings Yield

4.00%

Dividend Yield

1.53%

Payout Ratio

11.76%

Stock Overview

Market Cap

$21.81B

Shares Outstanding

646.21M

Volume

79.62K

Avg. Volume

95.50K

Financials (TTM)

Gross Profit

€12.24B

Operating Income

€3.83B

EBITDA

€6.22B

Operating Cash Flow

€4.16B

Capital Expenditure

-€1.86B

Free Cash Flow

€2.30B

Cash & ST Invst.

€3.77B

Total Debt

€12.05B

Merck KGaA Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

€5.13B

-2.8%

Gross Profit

€3.07B

-2.5%

Gross Margin

59.70%

N/A

Market Cap

$21.81B

N/A

Market Cap/Employee

$369.53K

N/A

Employees

59,020

N/A

Net Income

€659.00M

-10.3%

EBITDA

€1.47B

-2.5%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

€3.77B

+133.0%

Total Debt

€12.05B

+28.3%

Accounts Receivable

€4.44B

-0.7%

Inventory

€4.78B

+6.0%

Long Term Debt

€10.81B

+43.7%

Short Term Debt

€1.24B

-28.6%

Return on Assets

4.77%

N/A

Return on Invested Capital

9.30%

N/A

Free Cash Flow

€272.00M

+750.0%

Operating Cash Flow

€818.00M

+47.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
DSKYFDaiichi Sankyo Company, Limited
$15.74+0.25%
DSNKYDaiichi Sankyo Company, Limited
$16.45+2.94%
CMXHFCSL Limited
$83.18+3.79%
HLNCFHaleon plc
$4.82+6.64%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$17.92-0.01%
TAT&T
$20.58+0.00%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.30-0.15%
CLROClearOne
$6.48+1.01%

Questions About MKKGY

What is the current price of Merck KGaA?

Merck KGaA is trading at $33.75 per share.

What is the 52-week range for Merck KGaA?

Over the past 52 weeks, Merck KGaA has traded between $23.73 and $34.19.

How much debt does Merck KGaA have?

As of the most recent reporting period, Merck KGaA reported total debt of €13.87B.

How much cash does Merck KGaA have on hand?

Merck KGaA reported €3.16B in cash and cash equivalents in its most recent financial results.

What is Merck KGaA’s dividend yield?

Merck KGaA currently has a dividend yield of 1.53%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.